| Followers | 928 |
| Posts | 48536 |
| Boards Moderated | 0 |
| Alias Born | 07/22/2008 |
Tuesday, July 21, 2020 8:50:09 AM
Usually if anyone is "driving a stock down" it's because they want a lower strike point for a CONVERT (convertible note-to-share event)...
There aren't ANY convertibles here at SBFM. No convertible note debts, no convertible preferred shares...no converts period, nada, ain't none. Zilch. Why and who then would "drive the price down, beat it down"...??
NO DILUTION.
From SBFM 10Q:
The last known OS was 262 million. Current pps is $0.0305.
Gives SBFM a market cap of $7,991,000. Way way too low. Try $80,000,000...for starters. 10 bagger from here. 10x. 30¢s. For starters (wihin a week maybe 2). Still...no reason to drive her down. Yes, there will be profit takers. Everyone here should make profit from this amazing company, these amazing discoveries...no convertibles, no diluting MMs...
What if we get news today or tomorrow? Why would anyone try to "driver her down"...?
SBFM Strong Buy
There aren't ANY convertibles here at SBFM. No convertible note debts, no convertible preferred shares...no converts period, nada, ain't none. Zilch. Why and who then would "drive the price down, beat it down"...??
NO DILUTION.
From SBFM 10Q:
The last known OS was 262 million. Current pps is $0.0305.
Gives SBFM a market cap of $7,991,000. Way way too low. Try $80,000,000...for starters. 10 bagger from here. 10x. 30¢s. For starters (wihin a week maybe 2). Still...no reason to drive her down. Yes, there will be profit takers. Everyone here should make profit from this amazing company, these amazing discoveries...no convertibles, no diluting MMs...
What if we get news today or tomorrow? Why would anyone try to "driver her down"...?
SBFM Strong Buy
Recent SBFM News
- Sunshine Biopharma Reports Fiscal 2025 Revenue of $36.3 Million, a 4.1% Increase Over Prior Year • ACCESS Newswire • 04/06/2026 12:30:00 PM
- Sunshine Biopharma Gains FDA-Equivalent Clearance in Canada for Domperidone to Treat Cancer-related Nausea • ACCESS Newswire • 10/28/2025 11:45:00 AM
- Sunshine Biopharma Launches STD, Acne and Lyme Disease Therapy Doxycycline • ACCESS Newswire • 10/20/2025 11:45:00 AM
- Sunshine Biopharma Launches Cholesterol Fighting Medicine Pravastatin • ACCESS Newswire • 10/16/2025 11:45:00 AM
- Sunshine Biopharma Allocates $5 Million for Investment in Bitcoin as Strategic Reserve Asset to Enhance Treasury Resilience • ACCESS Newswire • 10/14/2025 11:00:00 AM
- Sunshine Biopharma and University of Arizona Develop a Potent New Series of Protease Inhibitors for Treatment of SARS Coronavirus Infections • ACCESS Newswire • 10/09/2025 12:00:00 PM
